Premium
Programmed cell death ligand 1 as a biomarker in head and neck cancer
Author(s) -
Pai Sara I.,
Faquin William C.
Publication year - 2017
Publication title -
cancer cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.29
H-Index - 57
eISSN - 1934-6638
pISSN - 1934-662X
DOI - 10.1002/cncy.21872
Subject(s) - medicine , head and neck cancer , head and neck , biomarker , programmed cell death 1 , ligand (biochemistry) , cancer , programmed cell death , oncology , cancer research , immune checkpoint , pd l1 , immunotherapy , apoptosis , surgery , receptor , biochemistry , chemistry
The evaluation of programmed cell death ligand 1 has a potential role in the application of immune checkpoint inhibitors for select cancers of the head and neck. See also pages 521‐8.